Evidence map›Paper›PMID 38983615›Full record

ArticleCurrent medical mycology2023

Mohsen Nosratabadi, Mohammad Ali Ebrahimzadeh, Seyedeh Roya Alizadeh, Iman Haghani, Leila Faeli, Robab Ebrahimi Barogh, Abdullah M S Al Hatmi, Mahdi Abastabar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current medical mycology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohsen NosratabadiStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad Ali EbrahimzadehDepartment of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Seyedeh Roya AlizadehDepartment of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Iman HaghaniDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Leila FaeliStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Robab Ebrahimi BaroghStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Abdullah M S Al HatmiNatural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman.
Mahdi AbastabarDepartment of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Materials and Methods: Results: The obtained results were intriguing since all five types of biosynthesized Se NPs demonstrated significantly higher antifungal activity, compared to antifungal drugs. It was found that Se NPs synthesized by Conclusion: Plant-based Se NPs demonstrated supreme antifungal activity and could be considered promising antifungal agents for

Indexed as

Antifungal activityFusarium speciesPlant extractSe NPs

Identifiers

PMID38983615
PMCPMC11230142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.